Anticholinergics are used in the treatment of Parkinson's disease, incontinence, nausea, asthma and some eye diseases (2). More than 600 drugs have unintended anticholinergic activity (2). The main ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.

Among adults with chronic rhinosinusitis with nasal polyps who endured endoscopic sinus surgery, those with severe vs. mild ...

A bill passed by New York lawmakers on June 12 would eliminate out-of-pocket costs for asthma inhalers if signed by Governor Kathy Hochul.

Dupilumab use in asthma is linked to higher lymphoma risk, especially T and NK cell types, but also shows reduced all-cause ...

Asthma is the most common chronic disease of childhood and, in the latter part of the 20th century, reached epidemic proportions. Asthma is generally believed to result from gene-environment ...

Around 60% of patients with uncontrolled asthma don't have high eosinophil levels, and that has led some analysts to predict blockbuster sales for tezepelumab if approved for marketing.

Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic ...

mild or moderate asthma before surgery more often had nasal polyp recurrence, according to study data. The FDA issued a warning about risk for severe itching after stopping long-term allergy ...

Clinical observations suggest that younger patients may be more sensitive to SGA-associated EPS than are adults and require therapy with anticholinergic agents. Objective: To determine the ...

18 months after saying "no" to regular NHS funding for Sanofi and Regeneron's Dupixent (dupilumab) for severe asthma in initial guidance, NICE has now backed the drug. The final appraisal ...

Research discoveries leading to the development of new pharmaceutical compounds are notoriously difficult to translate into clinical practice.1 Drug repurposing provides a strategy to identify ...